Business Context and Reporting Period
Company: Disc Medicine, Inc. (Nasdaq: IRON)
Filing Type: Form 8-K (Current Report)
Date of Report: February 27, 2025
Reporting Period: Fourth quarter and fiscal year ended December 31, 2024
Disc Medicine, Inc. filed this report to announce its financial results for the fourth quarter and full fiscal year 2024, along with a corporate update. The detailed financial data is contained within a press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided filing text serves as a cover document and does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being included in the attached press release (Exhibit 99.1), which is not part of the input text provided for analysis.
Note: The filing text does not provide a clear value for any specific financial metric.
Material Changes
No material changes versus the prior comparable period are detailed in the text of this Form 8-K. The document solely references the announcement of results without summarizing the specific variances or trends.
Guidance, Outlook, and Risks
Management Commentary: The company provided a corporate update alongside the financial results, though the specific content of this update is not included in the filing text.
Legal Status of Information: The information in Item 2.02 and Exhibit 99.1 is furnished and not deemed "filed" under Section 18 of the Exchange Act, nor is it incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q4 and FY2024 revenue, net loss, and cash burn figures.
- Verify the details of the "corporate update" mentioned in the announcement for strategic shifts or pipeline progress.
- Confirm current cash position and runway based on the full text of the press release.
- Check for any forward-looking guidance or updated clinical trial timelines not captured in this summary.